Bioxytran Stock Net Income
| BIXT Stock | USD 0.13 0.02 13.33% |
Bioxytran fundamentals help investors to digest information that contributes to Bioxytran's financial success or failures. It also enables traders to predict the movement of Bioxytran OTC Stock. The fundamental analysis module provides a way to measure Bioxytran's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioxytran otc stock.
Bioxytran |
Bioxytran OTC Stock Net Income Analysis
Bioxytran's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Bioxytran Net Income | (4.04 M) |
Most of Bioxytran's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioxytran is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Bioxytran reported net income of (4.04 Million). This is 101.18% lower than that of the Biotechnology sector and 105.77% lower than that of the Health Care industry. The net income for all United States stocks is 100.71% higher than that of the company.
Bioxytran Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioxytran's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Bioxytran could also be used in its relative valuation, which is a method of valuing Bioxytran by comparing valuation metrics of similar companies.Bioxytran is currently under evaluation in net income category among related companies.
Bioxytran Fundamentals
| Return On Asset | -7.04 | |||
| Current Valuation | 19.06 M | |||
| Shares Outstanding | 144.64 M | |||
| Shares Owned By Insiders | 65.60 % | |||
| Price To Sales | 532.56 X | |||
| EBITDA | (3.59 M) | |||
| Net Income | (4.04 M) | |||
| Cash And Equivalents | 500.68 K | |||
| Total Debt | 2.17 M | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (839.44 K) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 2.71 | |||
| Beta | -0.43 | |||
| Market Capitalization | 17.21 M | |||
| Total Asset | 370.94 K | |||
| Retained Earnings | (11.22 M) | |||
| Working Capital | (3.37 M) | |||
| Z Score | -80.36 | |||
| Net Asset | 370.94 K |
About Bioxytran Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioxytran's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioxytran using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioxytran based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bioxytran
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioxytran position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioxytran will appreciate offsetting losses from the drop in the long position's value.Moving against Bioxytran OTC Stock
| 0.43 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.43 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
The ability to find closely correlated positions to Bioxytran could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioxytran when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioxytran - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioxytran to buy it.
The correlation of Bioxytran is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioxytran moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioxytran moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioxytran can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioxytran. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Bioxytran OTC Stock analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |